European Drugmakers May Halt Some Production Amid Soaring Energy Costs; FDA Approves C. Diff Treatment
Reuters: Europe’s Generic Drugmakers Say They May Cut Output Due To Energy Bills Europe’s drugmakers have warned they may stop making some cheap generic medicines because of surging electricity costs and are calling for an overhaul of the way they…
Read More